GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Purchase Of Business

Nxera Pharma Co (FRA:JSS) Purchase Of Business : €0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Nxera Pharma Co Purchase Of Business?

Nxera Pharma Co's purchase of business for the three months ended in Mar. 2025 was €0.0 Mil. It means Nxera Pharma Co spent €0.0 Mil on purchasing business. Nxera Pharma Co's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Dec. 2024 ), Nxera Pharma Co spent the same money on purchasing business in Mar. 2025 (€0.0 Mil).

Nxera Pharma Co Purchase Of Business Historical Data

The historical data trend for Nxera Pharma Co's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Purchase Of Business Chart

Nxera Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -400.86 -

Nxera Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nxera Pharma Co Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Purchase Of Business
Comparable Companies
TSE:4974 TSE:4894 TSE:219A TSE:2160 TSE:4593 TSE:7774 TSE:4563 TSE:7776 TSE:4599 TSE:4575 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
SOLTF:USA 4565:Japan
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Website
https://www.nxera.life
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines